Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S27 pseudogene 28 (RPS27P28) is a processed pseudogene in the human genome, derived from the gene encoding ribosomal protein S27 (RPS27). Like most processed pseudogenes, it does not produce a functional protein and has no known biological, molecular, or disease-related activity. Multiple such pseudogenes exist for ribosomal proteins throughout the genome as a result of the retrotransposition process, where mRNA is copied back into DNA and inserted into new genomic locations, but the resulting pseudogene generally lacks coding capacity or functional role. The functional relevance of RPS27P28 has not been established, and it is not considered a therapeutic target or biomarker. Any references to ribosomal protein S27 as a therapeutic or disease-associated protein refer to the functional gene RPS27, not this pseudogene.
Not applicable (pseudogene, not a molecular target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S27 pseudogene 28 (RPS27P28).